Contineum Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Contineum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Contineum Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Contineum Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $270k | 16k | 16.39 |
| 2024-12-31 | $103k | 7.0k | 14.65 |
| 2024-06-30 | $34k | 1.9k | 17.61 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors